Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina
- Status
- COMPLETED
- Phase
- PHASE3
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus
- Status
- WITHDRAWN
- Phase
- PHASE3
Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
The Effect of Dilution and Prolonged Injection Time on Dexamethasone-induced Perineal Irritation
- Status
- UNKNOWN
- Phase
- NA
Selinexor in Combination With Immunomodulator （Thalidomide/Pomalidomide/Lenalidomide）in RRMM
- Status
- RECRUITING
- Phase
- PHASE2
Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.
- Status
- RECRUITING
- Phase
- PHASE2
Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY Disease
- Status
- TERMINATED
- Phase
- PHASE1
Granisetron Transdermal Patch for Prophylaxis of Delayed CINV
- Status
- UNKNOWN
- Phase
- PHASE3
The DEPOT Study (Dry Eye Prescription Options for Therapy)
- Status
- COMPLETED
- Phase
- PHASE4
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Impact of Steroids on Inflammatory Response in Covid-19
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Dexamethasone in Attenuation of Postinduction Hypotension in Geriatric Patients Undergoing General Anesthesia
- Status
- COMPLETED
- Phase
- PHASE4
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension
- Status
- TERMINATED
- Phase
- PHASE3